share_log

Supernus Pharmaceuticals Q1 Sales $143.600M Miss $145.832M Estimate

Benzinga ·  May 8 17:21

Supernus Pharmaceuticals (NASDAQ:SUPN) reported quarterly sales of $143.600 million which missed the analyst consensus estimate of $145.832 million by 1.53 percent. This is a 6.61 percent decrease over sales of $153.764 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment